Luminar Technologies (NASDAQ:LAZR – Get Rating) had its target price cut by Citigroup from $20.00 to $19.00 in a research note published on Tuesday, The Fly reports.
LAZR has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Luminar Technologies from $15.00 to $14.00 in a research note on Wednesday, March 1st. Rosenblatt Securities restated a neutral rating and set a $8.00 price target on shares of Luminar Technologies in a research note on Wednesday, March 1st. Finally, JPMorgan Chase & Co. upped their price target on shares of Luminar Technologies from $15.00 to $20.00 and gave the company an overweight rating in a research note on Monday, March 6th. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and a consensus price target of $14.00.
Luminar Technologies Trading Down 7.8 %
NASDAQ LAZR opened at $8.17 on Tuesday. The company has a quick ratio of 7.04, a current ratio of 7.15 and a debt-to-equity ratio of 14.23. The firm has a market cap of $3.02 billion, a PE ratio of -6.54 and a beta of 1.63. The company has a 50 day moving average price of $6.98 and a 200 day moving average price of $7.33. Luminar Technologies has a 52 week low of $3.91 and a 52 week high of $16.62.
Institutional Trading of Luminar Technologies
About Luminar Technologies
Luminar Technologies, Inc, an automotive technology company, provides sensor technologies and software for passenger cars and commercial trucks in North America, the Asia Pacific, Europe, and the Middle East. It operates in two segments, Autonomy Solutions and Components. The Autonomy Solutions segment designs, manufactures, and sells laser imaging, detection, and ranging sensors, as well as related perception and autonomy software solutions primarily for original equipment manufacturers in the automobile, commercial vehicle, robo-taxi, and adjacent industries.
- Get a free copy of the StockNews.com research report on Luminar Technologies (LAZR)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Luminar Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminar Technologies and related companies with MarketBeat.com's FREE daily email newsletter.